A Cross-Sectional Survey Investigating Māori and Non-Māori Cancer Patients' Views on Psychedelic-Assisted Therapy in Aotearoa New Zealand.
Georgia Best, Eva Morunga, Alesha Wells, Jenny Allison, Lisa Reynolds
J Psychoactive Drugs September 4, 2024 DOI: 10.1080/02791072.2024.2397427 via PubMed
Summary
AI-generated from the abstractMāori and non-Māori cancer patients in Aotearoa New Zealand show moderate openness to psychedelic-assisted therapy, with 42% of participants expressing interest. The survey of 100 patients found that Māori respondents were significantly more likely to view psychedelic-assisted therapy as acceptable compared to non-Māori respondents. Safety concerns and lack of information were the most common barriers across both groups. The findings suggest that cultural considerations and tailored education may be important for integrating such therapies into supportive cancer care.
Study at a glance
| Characteristics | Cross-sectional survey Peer reviewed |
|---|---|
| Sample size | 100 |
| Population | Cancer patients in Aotearoa New Zealand, including Māori and non-Māori |
| Topics | Psychedelic-assisted therapy |
| Keywords | Psychedelic-assisted treatment Hallucinogenic therapy Entheogenic medicine Mind-altering drug therapy |
| Citations | 1 |
| Key finding | Māori cancer patients were significantly more open to psychedelic-assisted therapy than non-Māori patients, though overall interest was moderate at 42%. |
Abstract
A Cross-Sectional Survey Investigating Māori and Non-Māori Cancer Patients' Views on Psychedelic-Assisted Therapy in Aotearoa New Zealand.